CYTODROX 500MG – Composition, Uses and Medicine Enquiries
Product Overview
CYTODROX 500MG is listed as a prescription product containing Hydroxyurea (500MG), marketed by Cipla Ltd. It belongs to the hematology and antineoplastic antimetabolite class and may be prescribed for selected blood disorders, including sickle cell disease, and certain cancers depending on approval.
The active medicine slows cell proliferation and can increase fetal hemoglobin in sickle cell disease.
Treatment suitability depends on the confirmed diagnosis, previous treatment, organ function and other medicines. The exact manufacturer pack, formulation, approved indication and administration schedule must be checked before treatment or publication.
A qualified clinician should assess suitability, interactions, contraindications and monitoring requirements. Regular blood counts and pregnancy and handling precautions are essential.
Composition and Strength
| Active Ingredient | Strength |
|---|---|
| Hydroxyurea | 500 mg |
Product Name: CYTODROX 500MG
Generic Name: Hydroxyurea
Brand Name: CYTODROX 500MG
Strength: 500 mg
Listed Marketer: Cipla Ltd
The exact dosage form and product presentation should be verified against the original manufacturer packaging.
Therapeutic Category and Indication
CYTODROX 500MG belongs to the hematology and antineoplastic medicine category and is classified as an antimetabolite.
It may be prescribed for selected blood disorders, including sickle cell disease, and certain cancers depending on approval.
Hydroxyurea slows cell proliferation and can increase fetal hemoglobin in sickle cell disease.
Treatment choice depends on the confirmed diagnosis, previous treatment, organ function and other medicines. The treating specialist determines the appropriate treatment and monitoring plan.
Administration Information
CYTODROX 500MG is listed as an oral capsule according to hematology or oncology specialist instructions.
Patients should follow the treating clinician’s instructions and the approved product label.
The dose should not be independently adjusted, safety monitoring should not be skipped and formulations should not be switched without medical advice.
Product Presentation and Availability
The product enquiry can be made using the following details:
- Product Name: CYTODROX 500MG
- Generic Name: Hydroxyurea
- Strength: 500 mg
- Therapeutic Category: Anticancer
- Medicine Class: Hematology / Antineoplastic; Antimetabolite
- Manufacturer Listed: Cipla Ltd
- Dosage Form: Oral capsule
The exact dosage form, pack size, batch, storage, expiry and product-specific presentation must be verified from the original manufacturer packaging and an authorised provider.
Product details and supply eligibility may vary by country.
Prescription and Patient Safety
CYTODROX 500MG is a prescription medicine that requires supervision by an appropriately qualified healthcare professional.
Treatment requires individual clinical assessment and regular monitoring.
Regular blood counts and pregnancy and handling precautions are essential. The treating specialist should assess potential interactions, contraindications and the patient’s overall clinical condition.
The exact precautions and monitoring requirements should be checked against the current approved product information.
Medicine Enquiry Coordination Through Medinglobal
Medinglobal is a healthcare coordination platform. It can receive medicine information requests and, where legally permissible, connect patients or institutions with appropriately authorised independent pharmaceutical providers.
Medinglobal does not itself sell, dispense, manufacture or export CYTODROX 500MG.
Product availability, lawful supply, prescription validation, commercial terms and destination requirements must be verified by the independent provider. Submitting an enquiry does not guarantee fulfilment.
How to Submit a CYTODROX 500MG Enquiry
To help identify the requested product, include the following details:
- Product or brand name: CYTODROX 500MG.
- Generic name: Hydroxyurea.
- Required strength and formulation.
- Required quantity.
- Destination country.
- Prescription or institutional documents, where required.
Medinglobal may coordinate an introduction to a suitably authorised provider, who independently verifies product details, regulatory eligibility and any transaction.
Frequently Asked Questions
What is CYTODROX 500MG used for?
It may be prescribed for selected blood disorders, including sickle cell disease, and certain cancers depending on approval. The prescriber confirms the approved use.
What is the composition of CYTODROX 500MG?
The supplied product information lists Hydroxyurea 500MG as its active ingredient.
How is CYTODROX 500MG administered?
It is listed as an oral capsule according to hematology or oncology specialist instructions.
Which company markets CYTODROX 500MG?
The supplied product catalogue lists Cipla Ltd.
What precautions are associated with CYTODROX 500MG?
Regular blood counts and pregnancy and handling precautions are essential during treatment.
Can Medinglobal supply CYTODROX 500MG directly?
No. Medinglobal coordinates medicine enquiries with independent authorised providers where legally permissible.




Reviews
There are no reviews yet.